Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

BLEXTEN 20 MG

BILASTINE : 20 MG · DIN 02454130 · ARALEZ PHARMACEUTICALS CANADA INC

Health Canada status: MARKETED

What is BLEXTEN?

BLEXTEN 20 MG contains BILASTINE : 20 MG. It is listed in the Health Canada Drug Product Database under DIN 02454130, held by ARALEZ PHARMACEUTICALS CANADA INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 30-May-2019. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

What is BLEXTEN used for?

BLEXTEN (bilastine) is indicated for the symptomatic relief of nasal and non-nasal symptoms of seasonal allergic rhinitis (SAR) in patients 4 years of age and older with a body weight of at least 16 kg. BLEXTEN (bilastine) is indicated for the relief of the symptoms associated with chronic spontaneous urticaria (CSU) (e.g. pruritus and hives), in patients 4 years of age and older with a body weight of at least 16 kg.

Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.

Product details and regulatory record

DIN02454130
Brand nameBLEXTEN
Generic / active ingredientBILASTINE : 20 MG
ManufacturerARALEZ PHARMACEUTICALS CANADA INC
Strength20 MG
Dosage formTABLET
Route of administrationORAL
SchedulePrescription
ATC codeR06AX29 BILASTINE
AHFS class04:08.00
BiosimilarNo
Health Canada statusMARKETED
Status date30-May-2019
Original market date2016-12-02 00:00:00

How is it stored and handled?

null

How is it supplied?

10 mg orodispersible tablet: blister packs containing 10 tablets, cartons contain 30 tablets. 20 mg tablet: blister packs containing 10 tablets, cartons contains 30 tablets. 2.5 mg/mL oral solution: amber glass bottle containing 120 mL oral solution, accompanied by a dosing cup.

What can be used instead?

Other Canadian products sharing ATC code R06AX29 BILASTINE. 10 of 10 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
AURO-BILASTINE20 MGTABLETAURO PHARMA INCMARKETEDDIN 02541556
BLEXTEN10 MGTABLET (ORALLY DISINTEGRATING)ARALEZ PHARMACEUTICALS CANADA INCMARKETEDDIN 02519038
BLEXTEN2.5 MGSOLUTIONARALEZ PHARMACEUTICALS CANADA INCMARKETEDDIN 02519011
GLN-BILASTINE20 MGTABLETGLENMARK PHARMACEUTICALS CANADA INC.MARKETEDDIN 02544369
JAMP BILASTINE20 MGTABLETJAMP PHARMA CORPORATIONMARKETEDDIN 02546795
M-BILASTINE20 MGTABLETMANTRA PHARMA INCMARKETEDDIN 02548410
MAR-BILASTINE20 MGTABLETMARCAN PHARMACEUTICALS INCMARKETEDDIN 02547279
NRA-BILASTINE20 MGTABLETNORA PHARMA INCMARKETEDDIN 02551934
SANDOZ BILASTINE20 MGTABLETSANDOZ CANADA INCORPORATEDMARKETEDDIN 02536269

Who else supplies BILASTINE worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. BILASTINE appears in 45 registered pack listings across 8 markets, published on 6 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for BLEXTEN

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Request a quote for BLEXTEN

Health Canada Drug Product Database (DPD), DIN 02454130. Last reviewed 2026-09-08. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.